BARCELONA, Spain, June 24 /PRNewswire/ --

- Visa and Globe Telecom Named as First Two Founding Partners

The GSMA, the body that represents the worldwide mobile communications industry, announced the launch of the Mobile Money Exchange initiative at the Annual Mobile Money Summit in Barcelona. Visa and Globe Telecom are the first two founding partners of the Mobile Money Exchange, which has been launched to engage with new stakeholders and sectors that are entering the mobile ecosystem.

HERZLIYA, Israel, June 24 /PRNewswire/ -- Volas Entertainment Ltd, part of Logia Group and a provider of mobile video solutions and value added managed services, have recently signed an agreement with leading mobile games developer Redboss Games, part of MLiven, to distribute and resell Redboss mobile games in Israel.

CARDIFF, Wales, June 24 /PRNewswire/ --

- World's First 'SaaS' Laboratory, Pre-Deployment and In-Life Test Solution

Epitiro, the broadband communications authority, today announced ISP-I(TM) WiMAX, the world's first 'software as a service' (SaaS) test solution for WiMAX service providers and manufacturers.

ISP-I(TM) WiMAX covers the key stages from device manufacture, to subscriber pre-test deployment and ultimately to in-life operation - providing key performance indicator (KPI) information at every stage. ISP-I(TM) WiMAX reports real-time IP-based service delivery metrics (not simulated) based on the quality of actual services as experienced by subscribers.

MOSCOW, June 24 /PRNewswire/ --

- Baker Botts Lawyers Counsel Russian Oil, Gas Company in Complex Oil Supply Transaction

A US $15 billion loan agreement between Russian oil and gas company Rosneft and the Chinese government is the first step in the development of a major oil supply contract between the two countries. The agreement, which closed in April of 2009, is one of the largest private loans booked in Russia this year.

BASINGSTOKE, England, June 24 /PRNewswire/ --

- Help is at Hand for the Frail Elderly at Risk of Falls and Fractures via a New Medication Support Programme

As National Falls Awareness Day takes place this week, a new programme called 'Be Active' is being launched to help those already prescribed bone health supplements to take them more regularly, helping to prevent falls and reduce the burden on the NHS.

BARCELONA, Spain and DALLAS, June 24 /PRNewswire/ --

- Innovative NTRadmin Bots Make IT Easy to Automate Daily IT Tasks

From the enterprise to SMBs, NTRadmin - NTRglobal's software-as-a-service (SaaS) for automating IT tasks, monitoring, diagnosing and securing hardware and software assets via remote control - is doing more than simplifying the workload for IT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081111/NTRGLOBALLOGO)

SYDNEY and AUCKLAND, New Zealand, June 24 /PRNewswire/ --

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that the New Zealand Minister of Health, the Honourable Tony Ryall, has authorized LCT's New Zealand Phase I/IIa clinical trial of DIABECELL(R) for insulin dependent diabetes.

The authorization confirms the conditions announced on 19 June 2009. One condition of the new authorization limits participation in the trial to patients with poorly controlled (brittle) diabetes. The remaining conditions are procedural rather than substantive in nature and LCT and the Middlemore Hospital clinical team conducting the trial, have requested the Regional Ethics Committee formally accept the changes required by the Minister.

AMSTERDAM, The Netherlands, June 24 /PRNewswire/ -- The U.S. Department of Energy's Pacific Northwest National Laboratory has signed an agreement with Avantium to enable the sale and delivery of an Avantium Flowrence(TM) parallel fixed bed reactor system. The Flowrence(TM) will allow PNNL to accelerate its catalyst research for infrastructure compatible biofuels and bioproducts.

CHARLOTTESVILLE, Virginia, June 24 /PRNewswire/ -- Biovista Inc. today announced that BVA-601, its small-molecule drug targeting epilepsy, has shown positive results in the Kainic acid murine model of temporal lobe epilepsy. BVA-601, an existing drug that Biovista repositioned in epilepsy, exhibits both anti-epileptic and neuroprotective activity. In this pre-clinical trial, BVA-601 induced a statistically significant decrease of epileptic activity in mice pre-treated with Kainic acid.

ABU DHABI, United Arab Emirates, TEANECK, New Jersey and CHENNAI, India, June 24 /PRNewswire/ --

- Builds the Middle East's First Online Health Insurance Portal to Help Daman's Customers Meet Their Health Insurance Needs Online